Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gibble

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Crohn'S & Colitis 360|January 21, 2025
Exit Interviews Exploring Patients' Experience of Change in Crohn's Disease Symptoms During the Mirikizumab Phase 3 Clinical Trial In Adult Patients With Moderately-to-Severely Crohn's DiseaseTheresa Hunter Gibble, Jake Macey, Harriet Makin, et al.
Diabetes, Obesity & Metabolism|February 25, 2025
Real-world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity databaseEmily R Hankosky, Chanadda Chinthammit, Alexandra Meeks, et al.
Diabetes, Obesity & Metabolism|November 4, 2025
Improved health-related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT-5 trialAlpana P Shukla, Julia P Dunn, Elisa Gomez Valderas, et al.
Transfusion|October 26, 2007
Pasteurella multocida bacteremia in asymptomatic plateletpheresis donors: a tale of two catsBarbara J Bryant, Cathy Conry-Cantilena, Alice Ahlgren, et al.
BMC Gastroenterology|March 9, 2023
Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn's disease and ulcerative colitis in the United StatesTheresa Hunter Gibble, April N Naegeli, Michael Grabner, et al.
Therapeutic Advances in Gastroenterology|April 19, 2021
Validation of claims-based indicators used to identify flare-ups in inflammatory bowel diseaseJohan Burisch, He Zhang, Casey Kar-Chan Choong, et al.
Advances in Therapy|November 24, 2023
Bowel Urgency in Patients with Ulcerative Colitis and Crohn's Disease: A Cross-Sectional Real-World Survey in JapanChaochen Wang, Tomoko Ishizuka, Masaru Tanaka, et al.
Journal of Patient-Reported Outcomes|November 12, 2024
Patient perception of bowel urgency and remission in moderately to severely active Crohn's disease or ulcerative colitis: a qualitative studyTheresa Hunter Gibble, Larissa Stassek, Gale Harding, et al.
Gastro Hep Advances|October 27, 2025
Bowel Urgency Severity Among Patients with Crohn's Disease or Ulcerative Colitis on Advanced Therapies: Real-World Data Using Study of a Prospective Adult Research Cohort with Inflammatory Bowel DiseaseJames D Lewis, Wai Man Maria Chan, Richard E Moses, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|October 9, 2018
Cs Fountain Clocks for Commercial Realizations-An Improved and Robust DesignRichard J Hendricks, Filip Ozimek, Krzysztof Szymaniec, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Crohn'S & Colitis 360|January 21, 2025
Exit Interviews Exploring Patients' Experience of Change in Crohn's Disease Symptoms During the Mirikizumab Phase 3 Clinical Trial In Adult Patients With Moderately-to-Severely Crohn's DiseaseTheresa Hunter Gibble, Jake Macey, Harriet Makin, et al.
Diabetes, Obesity & Metabolism|February 25, 2025
Real-world use and effectiveness of tirzepatide among individuals without type 2 diabetes: Results from the Optum Market Clarity databaseEmily R Hankosky, Chanadda Chinthammit, Alexandra Meeks, et al.
Diabetes, Obesity & Metabolism|November 4, 2025
Improved health-related quality of life with tirzepatide versus semaglutide in adults with obesity or overweight from the SURMOUNT-5 trialAlpana P Shukla, Julia P Dunn, Elisa Gomez Valderas, et al.
Transfusion|October 26, 2007
Pasteurella multocida bacteremia in asymptomatic plateletpheresis donors: a tale of two catsBarbara J Bryant, Cathy Conry-Cantilena, Alice Ahlgren, et al.
BMC Gastroenterology|March 9, 2023
Identification of inadequate responders to advanced therapy among commercially-insured adult patients with Crohn's disease and ulcerative colitis in the United StatesTheresa Hunter Gibble, April N Naegeli, Michael Grabner, et al.
Therapeutic Advances in Gastroenterology|April 19, 2021
Validation of claims-based indicators used to identify flare-ups in inflammatory bowel diseaseJohan Burisch, He Zhang, Casey Kar-Chan Choong, et al.
Advances in Therapy|November 24, 2023
Bowel Urgency in Patients with Ulcerative Colitis and Crohn's Disease: A Cross-Sectional Real-World Survey in JapanChaochen Wang, Tomoko Ishizuka, Masaru Tanaka, et al.
Journal of Patient-Reported Outcomes|November 12, 2024
Patient perception of bowel urgency and remission in moderately to severely active Crohn's disease or ulcerative colitis: a qualitative studyTheresa Hunter Gibble, Larissa Stassek, Gale Harding, et al.
Gastro Hep Advances|October 27, 2025
Bowel Urgency Severity Among Patients with Crohn's Disease or Ulcerative Colitis on Advanced Therapies: Real-World Data Using Study of a Prospective Adult Research Cohort with Inflammatory Bowel DiseaseJames D Lewis, Wai Man Maria Chan, Richard E Moses, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|October 9, 2018
Cs Fountain Clocks for Commercial Realizations-An Improved and Robust DesignRichard J Hendricks, Filip Ozimek, Krzysztof Szymaniec, et al.
Pageof 13